Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Purdue Pharma LP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Purdue Pharma Acquires Rights to VM-902A from VM Pharma 12
Venture Financing 13
Kolltan Pharma Raises US$60 Million In Series D Financing 13
Partnerships 15
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 15
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 16
University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 17
Purdue Pharma to Form Joint Venture with AnaBios 18
Eisai Enters into Agreement with Purdue Pharma 19
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 20
ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 21
Purdue Pharma Enters Into Co-Marketing Agreement With Transcept Pharma 22
Licensing Agreements 23
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 23
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 24
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 25
Purdue Pharma Enters into Licensing Agreement with Exicure 26
Purdue Pharma Enters into Licensing agreement with AnaBios 27
Purdue Pharma Enters into Licensing Agreement with Medical Developments 28
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 29
Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 30
Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 31
Purdue Pharma LP – Key Competitors 32
Purdue Pharma LP – Key Employees 33
Purdue Pharma LP – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Corporate Communications 35
Jun 22, 2017: Dr. Craig Landau Appointed President and CEO Purdue Pharma L.P. 35
Legal and Regulatory 36
May 31, 2017: Attorney General DeWine Files Lawsuit Against Opioid Manufacturers for Fraudulent Marketing; Fueling Opioid Epidemic 36
Government and Public Interest 37
Mar 01, 2016: Purdue Pharma Led Collaborative Assessment Identifies Alarming Number of Errors in Commonly Used Online Drug Information Compendia 37
Product News 38
Jun 12, 2017: Consumer Research Drives New Packaging Updates for Colace and Senokot Occasional Constipation Relief Products 38
04/06/2016: Purdue Pharma Canada Expresses Disappointment in reaction to Health Canada decision to not proceed with proposed regulations requiring tamper resistance for Oxycodone 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
Purdue Pharma LP, Pharmaceuticals & Healthcare, Key Facts 2
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Purdue Pharma LP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Purdue Pharma LP, Deals By Therapy Area, 2011 to YTD 2017 9
Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Purdue Pharma Acquires Rights to VM-902A from VM Pharma 12
Kolltan Pharma Raises US$60 Million In Series D Financing 13
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 15
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 16
University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 17
Purdue Pharma to Form Joint Venture with AnaBios 18
Eisai Enters into Agreement with Purdue Pharma 19
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 20
ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 21
Purdue Pharma Enters Into Co-Marketing Agreement With Transcept Pharma 22
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 23
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 24
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 25
Purdue Pharma Enters into Licensing Agreement with Exicure 26
Purdue Pharma Enters into Licensing agreement with AnaBios 27
Purdue Pharma Enters into Licensing Agreement with Medical Developments 28
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 29
Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 30
Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 31
Purdue Pharma LP, Key Competitors 32
Purdue Pharma LP, Key Employees 33
Purdue Pharma LP, Other Locations 34
Purdue Pharma LP, Subsidiaries 34